HBV screening often incomplete or forgone when starting tocilizumab, tofacitinibAugust 9, 2021Psoriatic Arthritis
Risk for MACEs higher in new users of IL12/23 and IL17 inhibitors vs TNF inhibitors in PsAJuly 26, 2021Psoriatic Arthritis
bDMARDs may mitigate risk for psoriatic arthritis in chronic plaque psoriasisJuly 26, 2021Psoriatic Arthritis
PsA: Tofacitinib shows more rapid improvement in pain compared with placeboJuly 26, 2021Psoriatic Arthritis
Secukinumab: A potentially effective first-line biologic therapy for PsAJuly 26, 2021Psoriatic Arthritis
PsA: Real-world safety and efficacy of TNF inhibitors and ustekinumab are comparableJuly 26, 2021Psoriatic Arthritis
Ultrasonography can help assess PsA disease activity, regardless of coexisting FMSJuly 26, 2021Psoriatic Arthritis
COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patientsJuly 21, 2021Psoriatic Arthritis
